Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Bio Essence Corp

OTC: BIOE · Life Sciences · 2 alerts · CIK 1723059

Share price
$0.4700Close, Nov 13
Market cap
$25.3M
Shares outstanding
53.81MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Bio Essence Corp filings on SEC EDGAR ↗

6:05 AM ET 10-Q
Financial Results

Bio Essence Q3 2026 Results: Net Loss of $150K

Bio Essence Corp. reported a net income of $324,992 for the nine months ended September 30, 2026, a significant improvement from a net loss of $132,890 in the prior year period. Despite this profitability, the company maintains a working capital deficit of $1,374,178 and an accumulated deficit of over $9.2 million, leading management to express substantial doubt about its ability to continue as a going concern.

Key figure
Net loss $150K
3:44 PM ET 8-K
Leadership Change

Bio Essence Leadership Change

Bio Essence Corp. appointed Thea Zhang and Geoff Fellows to its Board of Directors effective October 19, 2026, following approval by written consent from a majority of shareholders. In conjunction with these appointments, the company amended its bylaws to increase the maximum number of authorized directors from three to ten. The new directors bring experience in pharmaceutical operations, finance, and governance to the board.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.